Literature DB >> 12821483

Intracellular release of nitric oxide by NCX 972, an NO-releasing metronidazole, enhances in vitro killing of Entamoeba histolytica.

Anna Sannella1, Luigi Gradoni, Tiziana Persichini, Ennio Ongini, Giorgio Venturini, Marco Colasanti.   

Abstract

The activity of NCX 972, a new molecule obtained by adding a nitric oxide (NO) moiety to metronidazole, was tested against six isolates of Entamoeba histolytica in xenic cultures. NCX 972 released NO into trophozoite cells and enhanced killing of amoebas in a dose- and time-dependent manner compared to metronidazole.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821483      PMCID: PMC161880          DOI: 10.1128/AAC.47.7.2303-2306.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Nitric oxide and parasitic disease.

Authors:  I A Clark; K A Rockett
Journal:  Adv Parasitol       Date:  1996       Impact factor: 3.870

2.  Entamoeba taxonomy.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Temporal and anatomical distribution of nitric oxide synthase mRNA expression and nitric oxide production during central nervous system inflammation.

Authors:  M O López-Figueroa; H E Day; S Lee; C Rivier; H Akil; S J Watson
Journal:  Brain Res       Date:  2000-01-03       Impact factor: 3.252

4.  Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase.

Authors:  C Wassmann; A Hellberg; E Tannich; I Bruchhaus
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

Review 5.  Cysteine proteinases and the pathogenesis of amebiasis.

Authors:  X Que; S L Reed
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease.

Authors:  K B Seydel; S J Smith; S L Stanley
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 7.  NO inhibitions: antimicrobial properties of nitric oxide.

Authors:  M A De Groote; F C Fang
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

Review 8.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

9.  Specific labeling of cysteine proteinases in pathogenic and nonpathogenic Entamoeba histolytica.

Authors:  F de Meester; E Shaw; H Scholze; T Stolarsky; D Mirelman
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine.

Authors:  J Y Lin; K Chadee
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

View more
  1 in total

Review 1.  Nitroaromatic Antibiotics as Nitrogen Oxide Sources.

Authors:  Allison M Rice; Yueming Long; S Bruce King
Journal:  Biomolecules       Date:  2021-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.